Authors:
Bakkus, MHC
Asosingh, K
Vanderkerken, K
Thielemans, K
Hagemeijer, A
De Raeve, H
Van Camp, B
Citation: Mhc. Bakkus et al., Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour, LEUKEMIA, 15(7), 2001, pp. 1127-1132
Authors:
Asosingh, K
De Raeve, H
Croucher, P
Goes, E
Van Riet, I
Van Camp, B
Vanderkerken, K
Citation: K. Asosingh et al., In vivo homing and differentiation characteristics of mature (CD45(-)) andimmature (CD45(+)) 5T multiple myeloma cells, EXP HEMATOL, 29(1), 2001, pp. 77-84
Authors:
Luo, DZ
Vanderkerken, K
Chen, MC
Vermijlen, D
Asosingh, K
Willems, E
Triantis, V
Eizirik, DL
Kuppen, PJK
Wisse, E
Citation: Dz. Luo et al., Rat hepatic natural killer cells (Pit cells) express mRNA and protein similar to in vitro interleukin-2 activated spleen natural killer cells, CELL IMMUN, 210(1), 2001, pp. 41-48
Authors:
Asosingh, K
Gunthert, U
De Raeve, H
Van Riet, I
Van Camp, B
Vanderkerken, K
Citation: K. Asosingh et al., A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium, CANCER RES, 61(7), 2001, pp. 2862-2865
Authors:
Broek, IV
Vanderkerken, K
De Greef, C
Asosingh, K
Straetmans, N
Van Camp, B
Van Riet, I
Citation: Iv. Broek et al., Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor, BR J CANC, 85(9), 2001, pp. 1387-1395
Authors:
Croucher, PI
Shipman, CM
Lippitt, J
Perry, M
Asosingh, K
Hijzen, A
Brabbs, AC
van Beek, EJR
Holen, I
Skerry, TM
Dunstan, CR
Russell, GR
Van Camp, B
Vanderkerken, K
Citation: Pi. Croucher et al., Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma, BLOOD, 98(13), 2001, pp. 3534-3540
Authors:
Asosingh, K
Gunthert, U
Bakkus, MHC
De Raeve, H
Goes, E
Van Riet, I
Van Camp, B
Vanderkerken, K
Citation: K. Asosingh et al., In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells, CANCER RES, 60(11), 2000, pp. 3096-3104
Authors:
Shipman, CM
Vanderkerken, K
Rogers, MJ
Lippitt, JM
Asosingh, K
Hughes, DE
Van Camp, B
Russell, RGG
Croucher, PI
Citation: Cm. Shipman et al., The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma, BR J HAEM, 111(1), 2000, pp. 283-286
Authors:
Vanderkerken, K
De Greef, C
Asosingh, K
Arteta, B
De Veerman, M
Vande Broek, I
Van Riet, I
Kobayashi, M
Smedsrod, B
Van Camp, B
Citation: K. Vanderkerken et al., Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse, BR J CANC, 82(4), 2000, pp. 953-959
Authors:
Luo, DZ
Vermijlen, D
Vanderkerken, K
Kuppen, PJK
Seynaeve, C
Eddouks, M
Baekeland, M
Wisse, E
Citation: Dz. Luo et al., Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells, J HEPATOL, 31(1), 1999, pp. 110-116
Authors:
Vanderkerken, K
Asosingh, K
Braet, F
Van Riet, I
Van Camp, B
Citation: K. Vanderkerken et al., Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells, BLOOD, 93(1), 1999, pp. 235-241
Authors:
Luo, D
Vermijlen, D
Vanderkerken, K
Kuppen, PJK
Seynaeve, C
Eddouks, M
Wisse, E
Citation: D. Luo et al., Participation of CD45 on pit cells and MHC class I on target cells in rat hepatic NK cell (pit cell)-mediated cytotoxicity against colon carcinoma cells, CELLS OF THE HEPATIC SINUSOID, VOL 7, 1999, pp. 287-291